Associations of Serum MicroRNA with Bone Mineral Density in Community-Dwelling Subjects: The Yakumo Study

Table 1

Comparison of characteristics between subjects with bone mineral density T‐scores> -1 (normal) and <−2.5 (osteoporotic).

Female			Male
Number	51	95		53	30
Age			<0.001			0.45
BMI			0.61			0.48
Postmenopause	31 (60.8)	88 (89.8)	<0.001
Smoking (%)	15 (29.4)	17 (17.9)	0.11	31 (58.4)	26 (86.7)	0.008
HL (%)	9 (17.6)	18 (19.0)	0.85	10 (18.9)	8 (26.7)	0.41
HT (%)	12 (23.5)	39 (41.1)	0.03	22 (41.5)	17 (56.7)	0.18
DM (%)	3 (5.9)	7 (7.4)	0.74	3 (5.7)	7 (23.3)	0.02
Heart ischemia (%)	1 (2.0)	6 (6.3)	0.24	2 (3.8)	3 (10.0)	0.25
Brain ischemia (%)	0 (0)	2 (2.1)	0.30	2 (3.8)	0 (0)	0.28
Liver disease (%)	5 (9.8)	9 (9.5)	0.95	4 (7.5)	3 (10.0)	0.70
CRP						0.69
let7d						0.79
miR1						0.81
miR17						0.10
miR20a						0.49
miR21						0.54
miR27a						0.72
miR34a						0.39
miR92						0.46
miR103a						0.56
miR122						0.46
miR126						0.73
miR130a						0.41
miR133a						0.09
miR146						0.12
miR150						0.05
miR192						0.67
miR195						0.42
miR197						0.12
miR199						0.98
miR221						0.95
miR222						0.05
miR320						0.16

BMI: body mass index; HL: hyperlipidemia; DM: diabetes mellitus; HT: hypertension; CRP: high-sensitivity C-reactive protein.